• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . Cytokine Storm in Severe COVID-19 Pneumonia

tetano

Editor, Senior Moderator
J Med Virol


. 2021 May 8.
doi: 10.1002/jmv.27068. Online ahead of print.
Cytokine Storm in Severe COVID-19 Pneumonia


Beng?l G?rsoy[SUP] 1 [/SUP], Cemile Dil?ah S?rmeli[SUP] 1 [/SUP], Mustafa Alkan[SUP] 2 [/SUP], Celal Sat?c?[SUP] 1 [/SUP], Sarg?n Altunok[SUP] 3 [/SUP], Sadettin Kamat[SUP] 1 [/SUP], Berna G?rb?z[SUP] 4 [/SUP], Mustafa As?m Demirkol[SUP] 1 [/SUP], Akaberk B?r?[SUP] 5 [/SUP]



Affiliations

Abstract

Objective: In this study, laboratorial parameters of hospitalized covid -19 patients, who were complicated with severe pneumonia, were compared with the findings of cytokine storm developing in macrophage activation syndrome (MAS)/secondary hemophagocytic lymphohistiocytosis(sHLH). Severe pneumonia occurred as a result of cytokine storm in some patients who needed intensive care unit(ICU), and it is aimed to determine the precursive parameters in this situation. Also in this study, the aim is to identify laboratory criteria that predict worsening disease and ICU intensification, as well as the development of cytokine storm.
Methods: This article comprises a retrospective cohort study of patients admitted to a single institution with COVID-19 pneumonia. This study includes 150 confirmed Covid-19 patients with severe pneumonia. When they were considered as severe pneumonia patients, the clinic and laboratory parameters of this group are compared with H-score criteria. Patients are divided into two subgroups; patients with worsened symptoms who were transferred into tertiary ICU, and patients with stable symptoms followed in the clinic.
Results: For the patients with confirmed Covid-19 infection, after they become complicated with severe pneumonia, lymphocytopenia (55.3%), anemia (12.0%), thrombocytopenia (19.3%), hyperferritinemia (72.5%), hyperfibrinogenemia (63.7%) and elevated LDH (90.8%), aspartate aminotransaminase (AST) (31.3%), alanine aminotransaminase (ALT) (20.7%) are detected. There were no significant changes in other parameters. Blood parameters between the pre-ICU period and the ICU period (In which their situation had been worsened and acute respiratory distress syndrome (ARDS) was developed) were also compared. In the latter group lymphocyte levels were found significantly reduced (p=0.01), and lactate dehydrogenase (LDH), highly sensitive troponin (hsTroponin), procalcitonin, and triglyceride levels were significantly increased (p<0.05). In addition, there was no change in hemoglobin, leukocyte, platelet, ferritin and liver function test levels, including patients who developed ARDS, similar to the cytokine storm developed in MAS / sHLH.
Conclusion: Covid-19 pneumonia has similar findings as hyperinflammatory syndromes but does not seem to have typical features as in cytokine storm developed in MAS / sHLH. In the severe patient group who has started to develop acute respiratory distress sydrome (ARDS) signs, a decrease in lymphocyte level in addition to the elevated LDH, hsTroponin, procalcitonin, and triglyceride levels can be a predictor in progression to ICU admission and could help in the planning of anti-cytokine therapy. This article is protected by copyright. All rights reserved.

Keywords: Coronavirus < Virus classification; Immnopathology < Immune responses; Inflammation < Immune responses.
 
Back
Top Bottom